Optimization of Hippocampus Sparing During Whole Brain Radiation Therapy with Simultaneous Integrated Boost-tutorial and Efficacy of Complete Directional Hippocampal Blocking

Overview

Journal Strahlenther Onkol

Specialties Oncology
Radiology

Date 2022 Mar 31

PMID 35357511

Authors

Ilinca Popp

Anca Ligia Grosu

Jamina Tara Fennell

Melissa Fischer

Dimos Baltas

Rolf Wiehle

Affiliations

Soon will be listed here.

Abstract

Purpose: Hippocampus-avoidance whole brain radiotherapy with simultaneous integrated boost (HA-WBRT+SIB) is a complex treatment option for patients with multiple brain metastases, aiming to prevent neurocognitive decline and simultaneously increase tumor control. Achieving efficient hippocampal dose reduction in this context can be challenging. The aim of the current study is to present and analyze the efficacy of complete directional hippocampal blocking in reducing the hippocampal dose during HA-WBRT+SIB.

Methods: A total of 30 patients with multiple metastases having undergone HA-WBRT+SIB were identified. The prescribed dose was 30 Gy in 12 fractions to the whole brain, with 98% of the hippocampus receiving ≤ 9 Gy and 2% ≤ 17 Gy and with SIB to metastases/resection cavities of 36-51 Gy in 12 fractions. Alternative treatment plans were calculated using complete directional hippocampal blocking and compared to conventional plans regarding target coverage, homogeneity, conformity, dose to hippocampi and organs at risk.

Results: All alternative plans reached prescription doses. Hippocampal blocking enabled more successful sparing of the hippocampus, with a mean dose of 8.79 ± 0.99 Gy compared to 10.07 ± 0.96 Gy in 12 fractions with the conventional method (p < 0.0001). The mean dose to the whole brain (excluding metastases and hippocampal avoidance region) was 30.52 ± 0.80 Gy with conventional planning and 30.28 ± 0.11 Gy with hippocampal blocking (p = 0.11). Target coverage, conformity and homogeneity indices for whole brain and metastases, as well as doses to organs at risk were similar between planning methods (p > 0.003).

Conclusion: Complete directional hippocampal blocking is an efficient method for achieving improved hippocampal sparing during HA-WBRT+SIB.

Citing Articles

A dosimetric comparison of non-coplanar volumetric modulated arc therapy and non-coplanar fixed field intensity modulated radiation therapy in hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for brain....

Zeng H, Zhong M, Chen Z, Tang S, Wen Z Front Oncol. 2025; 14:1428329.

PMID: 39917360 PMC: 11799273. DOI: 10.3389/fonc.2024.1428329.

Outcome of whole brain irradiation with a dose-escalated simultaneous-integrated boost in patients with multiple large and/or diffuse brain metastases: real live data and review of the literature.

Agolli L, Nicosia L, Hilger T, Iancu G, Exeli A, Eul B Discov Oncol. 2024; 15(1):336.

PMID: 39110335 PMC: 11306485. DOI: 10.1007/s12672-024-01176-w.

Neuroprotection in radiotherapy of brain metastases: A pattern-of-care analysis in Germany, Austria and Switzerland by the German Society for radiation Oncology - working group Neuro-Radio-Oncology (DEGRO AG-NRO).

Gleim N, Ruhle A, Heider S, Nagler F, Giordano F, Combs S Clin Transl Radiat Oncol. 2024; 47:100783.

PMID: 38706724 PMC: 11063589. DOI: 10.1016/j.ctro.2024.100783.

Hippocampus substructure segmentation using morphological vision transformer learning.

Lei Y, Ding Y, Qiu R, Wang T, Roper J, Fu Y Phys Med Biol. 2023; 68(23).

PMID: 37972414 PMC: 10690959. DOI: 10.1088/1361-6560/ad0d45.

Treatment of Central Nervous System Tumors on Combination MR-Linear Accelerators: Review of Current Practice and Future Directions.

Bryant J, Doniparthi A, Weygand J, Cruz-Chamorro R, Oraiqat I, Andreozzi J Cancers (Basel). 2023; 15(21).

PMID: 37958374 PMC: 10649155. DOI: 10.3390/cancers15215200.

References

Hsu F, Carolan H, Nichol A, Cao F, Nuraney N, Lee R . Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for 1-3 brain metastases: a feasibility study using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys. 2009; 76(5):1480-5. DOI: 10.1016/j.ijrobp.2009.03.032. View

Sun Q, Li M, Wang G, Xu H, He Z, Zhou Y . Distribution of metastasis in the brain in relation to the hippocampus: a retrospective single-center analysis of 565 metastases in 116 patients. Cancer Imaging. 2019; 19(1):2. PMC: 6341547. DOI: 10.1186/s40644-019-0188-6. View

Mizumatsu S, Monje M, Morhardt D, Rola R, Palmer T, Fike J . Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 2003; 63(14):4021-7. View

Redmond K, Hales R, Anderson-Keightly H, Zhou X, Kummerlowe M, Sair H . Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2017; 98(3):603-611. DOI: 10.1016/j.ijrobp.2017.03.009. View

Brinkman T, Reddick W, Luxton J, Glass J, Sabin N, Srivastava D . Cerebral white matter integrity and executive function in adult survivors of childhood medulloblastoma. Neuro Oncol. 2012; 14 Suppl 4:iv25-36. PMC: 3480251. DOI: 10.1093/neuonc/nos214. View

Gondi V, Pugh S, Tome W, Caine C, Corn B, Kanner A . Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014; 32(34):3810-6. PMC: 4239303. DOI: 10.1200/JCO.2014.57.2909. View

Ma T, Grimm J, McIntyre R, Anderson-Keightly H, Kleinberg L, Hales R . A prospective evaluation of hippocampal radiation dose volume effects and memory deficits following cranial irradiation. Radiother Oncol. 2017; 125(2):234-240. PMC: 9161646. DOI: 10.1016/j.radonc.2017.09.035. View

Popp I, Rau S, Hintz M, Schneider J, Bilger A, Fennell J . Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases. Cancer. 2020; 126(11):2694-2703. DOI: 10.1002/cncr.32787. View

Brown P, Gondi V, Pugh S, Tome W, Wefel J, Armstrong T . Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. J Clin Oncol. 2020; 38(10):1019-1029. PMC: 7106984. DOI: 10.1200/JCO.19.02767. View

10.

Seibert T, Karunamuni R, Bartsch H, Kaifi S, Krishnan A, Dalia Y . Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys. 2017; 97(2):263-269. PMC: 5267344. DOI: 10.1016/j.ijrobp.2016.10.035. View

11.

Yamamoto M, Serizawa T, Shuto T, Akabane A, Higuchi Y, Kawagishi J . Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014; 15(4):387-95. DOI: 10.1016/S1470-2045(14)70061-0. View

12.

Li J, Bentzen S, Renschler M, Mehta M . Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol. 2007; 25(10):1260-6. DOI: 10.1200/JCO.2006.09.2536. View

13.

Prokic V, Wiedenmann N, Fels F, Schmucker M, Nieder C, Grosu A . Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: a planning study on treatment concepts. Int J Radiat Oncol Biol Phys. 2012; 85(1):264-70. DOI: 10.1016/j.ijrobp.2012.02.036. View

14.

Chang C, Mok G, Shueng P, Yeh H, Shiau A, Tien H . Fan-shaped complete block on helical tomotherapy for esophageal cancer: a phantom study. Biomed Res Int. 2015; 2015:959504. PMC: 4342177. DOI: 10.1155/2015/959504. View

15.

Gutierrez A, Westerly D, Tome W, Jaradat H, Mackie T, Bentzen S . Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys. 2007; 69(2):589-97. PMC: 2350212. DOI: 10.1016/j.ijrobp.2007.05.038. View

16.

Brown P, Jaeckle K, Ballman K, Farace E, Cerhan J, Anderson S . Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA. 2016; 316(4):401-409. PMC: 5313044. DOI: 10.1001/jama.2016.9839. View

17.

Oehlke O, Wucherpfennig D, Fels F, Frings L, Egger K, Weyerbrock A . Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival. Strahlenther Onkol. 2015; 191(6):461-9. DOI: 10.1007/s00066-014-0808-9. View

18.

Yeh H, Huang Y, Wang L, Shueng P, Tien H, Chang C . Helical tomotherapy with a complete-directional-complete block technique effectively reduces cardiac and lung dose for left-sided breast cancer. Br J Radiol. 2020; 93(1108):20190792. PMC: 7362916. DOI: 10.1259/bjr.20190792. View

19.

Steinmann D, Vordermark D, Gerstenberg W, Aschoff R, Gharbi N, Muller A . Quality of life in patients with limited (1-3) brain metastases undergoing stereotactic or whole brain radiotherapy : A prospective study of the DEGRO QoL working group. Strahlenther Onkol. 2019; 196(1):48-57. DOI: 10.1007/s00066-019-01506-w. View

20.

Gondi V, Hermann B, Mehta M, Tome W . Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors. Int J Radiat Oncol Biol Phys. 2012; 83(4):e487-93. PMC: 3462659. DOI: 10.1016/j.ijrobp.2011.10.021. View